Whole-genome characterization of chemoresistant ovarian cancer.

Saved in:
Bibliographic Details
Title: Whole-genome characterization of chemoresistant ovarian cancer.
Authors: Patch, Ann-Marie, Christie, Elizabeth L., Etemadmoghadam, Dariush, Garsed, Dale W., George, Joshy, Fereday, Sian, Nones, Katia, Cowin, Prue, Alsop, Kathryn, Bailey, Peter J., Kassahn, Karin S., Newell, Felicity, Quinn, Michael C. J., Kazakoff, Stephen, Quek, Kelly, Wilhelm-Benartzi, Charlotte, Curry, Ed, Leong, Huei San, Hamilton, Anne, Mileshkin, Linda
Source: Nature. 5/28/2015, Vol. 521 Issue 7553, p489-494. 6p.
Subjects: Ovarian cancer, Cancer chemotherapy, Cancer genetics, Nucleotide sequence, BRCA genes
Abstract: Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. We show that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance. CCNE1 amplification was common in primary resistant and refractory disease. We observed several molecular events associated with acquired resistance, including multiple independent reversions of germline BRCA1 or BRCA2 mutations in individual patients, loss of BRCA1 promoter methylation, an alteration in molecular subtype, and recurrent promoter fusion associated with overexpression of the drug efflux pump MDR1. [ABSTRACT FROM AUTHOR]
Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 103043647
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Whole-genome characterization of chemoresistant ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Patch%2C+Ann-Marie%22">Patch, Ann-Marie</searchLink><br /><searchLink fieldCode="AR" term="%22Christie%2C+Elizabeth+L%2E%22">Christie, Elizabeth L.</searchLink><br /><searchLink fieldCode="AR" term="%22Etemadmoghadam%2C+Dariush%22">Etemadmoghadam, Dariush</searchLink><br /><searchLink fieldCode="AR" term="%22Garsed%2C+Dale+W%2E%22">Garsed, Dale W.</searchLink><br /><searchLink fieldCode="AR" term="%22George%2C+Joshy%22">George, Joshy</searchLink><br /><searchLink fieldCode="AR" term="%22Fereday%2C+Sian%22">Fereday, Sian</searchLink><br /><searchLink fieldCode="AR" term="%22Nones%2C+Katia%22">Nones, Katia</searchLink><br /><searchLink fieldCode="AR" term="%22Cowin%2C+Prue%22">Cowin, Prue</searchLink><br /><searchLink fieldCode="AR" term="%22Alsop%2C+Kathryn%22">Alsop, Kathryn</searchLink><br /><searchLink fieldCode="AR" term="%22Bailey%2C+Peter+J%2E%22">Bailey, Peter J.</searchLink><br /><searchLink fieldCode="AR" term="%22Kassahn%2C+Karin+S%2E%22">Kassahn, Karin S.</searchLink><br /><searchLink fieldCode="AR" term="%22Newell%2C+Felicity%22">Newell, Felicity</searchLink><br /><searchLink fieldCode="AR" term="%22Quinn%2C+Michael+C%2E+J%2E%22">Quinn, Michael C. J.</searchLink><br /><searchLink fieldCode="AR" term="%22Kazakoff%2C+Stephen%22">Kazakoff, Stephen</searchLink><br /><searchLink fieldCode="AR" term="%22Quek%2C+Kelly%22">Quek, Kelly</searchLink><br /><searchLink fieldCode="AR" term="%22Wilhelm-Benartzi%2C+Charlotte%22">Wilhelm-Benartzi, Charlotte</searchLink><br /><searchLink fieldCode="AR" term="%22Curry%2C+Ed%22">Curry, Ed</searchLink><br /><searchLink fieldCode="AR" term="%22Leong%2C+Huei+San%22">Leong, Huei San</searchLink><br /><searchLink fieldCode="AR" term="%22Hamilton%2C+Anne%22">Hamilton, Anne</searchLink><br /><searchLink fieldCode="AR" term="%22Mileshkin%2C+Linda%22">Mileshkin, Linda</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Nature%22">Nature</searchLink>. 5/28/2015, Vol. 521 Issue 7553, p489-494. 6p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Ovarian+cancer%22">Ovarian cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+chemotherapy%22">Cancer chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+genetics%22">Cancer genetics</searchLink><br /><searchLink fieldCode="DE" term="%22Nucleotide+sequence%22">Nucleotide sequence</searchLink><br /><searchLink fieldCode="DE" term="%22BRCA+genes%22">BRCA genes</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. We show that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance. CCNE1 amplification was common in primary resistant and refractory disease. We observed several molecular events associated with acquired resistance, including multiple independent reversions of germline BRCA1 or BRCA2 mutations in individual patients, loss of BRCA1 promoter methylation, an alteration in molecular subtype, and recurrent promoter fusion associated with overexpression of the drug efflux pump MDR1. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=103043647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/nature14410
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 489
    Subjects:
      – SubjectFull: Ovarian cancer
        Type: general
      – SubjectFull: Cancer chemotherapy
        Type: general
      – SubjectFull: Cancer genetics
        Type: general
      – SubjectFull: Nucleotide sequence
        Type: general
      – SubjectFull: BRCA genes
        Type: general
    Titles:
      – TitleFull: Whole-genome characterization of chemoresistant ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patch, Ann-Marie
      – PersonEntity:
          Name:
            NameFull: Christie, Elizabeth L.
      – PersonEntity:
          Name:
            NameFull: Etemadmoghadam, Dariush
      – PersonEntity:
          Name:
            NameFull: Garsed, Dale W.
      – PersonEntity:
          Name:
            NameFull: George, Joshy
      – PersonEntity:
          Name:
            NameFull: Fereday, Sian
      – PersonEntity:
          Name:
            NameFull: Nones, Katia
      – PersonEntity:
          Name:
            NameFull: Cowin, Prue
      – PersonEntity:
          Name:
            NameFull: Alsop, Kathryn
      – PersonEntity:
          Name:
            NameFull: Bailey, Peter J.
      – PersonEntity:
          Name:
            NameFull: Kassahn, Karin S.
      – PersonEntity:
          Name:
            NameFull: Newell, Felicity
      – PersonEntity:
          Name:
            NameFull: Quinn, Michael C. J.
      – PersonEntity:
          Name:
            NameFull: Kazakoff, Stephen
      – PersonEntity:
          Name:
            NameFull: Quek, Kelly
      – PersonEntity:
          Name:
            NameFull: Wilhelm-Benartzi, Charlotte
      – PersonEntity:
          Name:
            NameFull: Curry, Ed
      – PersonEntity:
          Name:
            NameFull: Leong, Huei San
      – PersonEntity:
          Name:
            NameFull: Hamilton, Anne
      – PersonEntity:
          Name:
            NameFull: Mileshkin, Linda
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 5/28/2015
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-print
              Value: 00280836
          Numbering:
            – Type: volume
              Value: 521
            – Type: issue
              Value: 7553
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1